En español
NIDA

Intensive intervention increases clinical adherence to opioid prescribing guidelines in chronic care

Science Spotlight

June 26, 2017

Rx and prescription tabletPhoto by ©iStock.com/18percentgrey

There is much discussion on the safety and effectiveness of prescribing opioids for chronic pain patients. While the Centers for Disease Control and Prevention has issued clinical guidelines for chronic opioid therapy, these guidelines are not followed by many medical practices.

A NIDA-funded randomized controlled trial that compared two organizational strategies to improve adherence to guidelines suggests that a multi component approach is more effective than electronic decision tools alone. The more intensive intervention included a nurse care manager, a suite of online tools, and advice and assistance from an expert in opiate prescribing (i.e., academic detailing).  While the multicomponent intervention improved adherence to the guideline-recommended monitoring of patients with chronic pain, it did not decrease early opioid refills. Further research is needed to determine whether guideline adherence reduces opioid-related risks.

For a copy of the paper — "Improving Adherence to Chronic Opioid Therapy Guidelines to Reduce Opioid Misuse in Primary Care: A Cluster Randomized Controlled Trial"— published in JAMA Internal Medicine, go to: http://jamanetwork.com/journals/jamainternalmedicine/fullarticle/2643777.

For information about opioids, go to: https://www.drugabuse.gov/drugs-abuse/opioids.

For more information, contact the NIDA press office at media@nida.nih.gov or 301-443-6245. Follow NIDA on Twitter and Facebook

Contact:
NIDA Press Office
301-443-6245
media@nida.nih.gov

About the National Institute on Drug Abuse (NIDA): The National Institute on Drug Abuse (NIDA) is a component of the National Institutes of Health, U.S. Department of Health and Human Services. NIDA supports most of the world’s research on the health aspects of drug use and addiction. The Institute carries out a large variety of programs to inform policy, improve practice, and advance addiction science. Fact sheets on the health effects of drugs and information on NIDA research and other activities can be found at www.drugabuse.gov, which is now compatible with your smartphone, iPad or tablet. To order publications in English or Spanish, call NIDA’s DrugPubs research dissemination center at 1-877-NIDA-NIH or 240-645-0228 (TDD) or email requests to drugpubs@nida.nih.gov. Online ordering is available at drugpubs.drugabuse.gov. NIDA’s media guide can be found at www.drugabuse.gov/publications/media-guide/dear-journalist, and its easy-to-read website can be found at www.easyread.drugabuse.gov. You can follow NIDA on Twitter and Facebook.

About the National Institutes of Health (NIH): NIH, the nation's medical research agency, includes 27 Institutes and Centers and is a component of the U.S. Department of Health and Human Services. NIH is the primary federal agency conducting and supporting basic, clinical, and translational medical research, and is investigating the causes, treatments, and cures for both common and rare diseases. For more information about NIH and its programs, visit www.nih.gov.

NIH. . .Turning Discovery Into Health®

News Releases

2017

2016

2015

2014

2013

2012

2011

2010

Get this Publication

    Cite this article

    NIDA. (2017, June 26). Intensive intervention increases clinical adherence to opioid prescribing guidelines in chronic care. Retrieved from https://www.drugabuse.gov/news-events/news-releases/2017/06/intensive-intervention-increases-clinical-adherence-to-opioid-prescribing-guidelines-in-chronic-care

    press ctrl+c to copy
    Receive Latest Science Articles in your Email!
    You will only receive messages related to Latest Science